Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jared Sivinski

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Seminars in Cancer Biology|June 8, 2021
Targeting NRF2 to treat cancerJared Sivinski, Donna D Zhang, Eli Chapman
Analytical Chemistry|October 27, 2021
UniDecCD: Deconvolution of Charge Detection-Mass Spectrometry DataMarius M Kostelic, Ciara K Zak, Yang Liu, et al.
Bioorganic & Medicinal Chemistry|October 2, 2020
Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugsMckayla Stevens, Chris Howe, Anne-Marie Ray, et al.
Bioorganic & Medicinal Chemistry|May 10, 2021
Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancerAnne-Marie Ray, Nilshad Salim, Mckayla Stevens, et al.
European Journal of Organic Chemistry|December 21, 2019
A one-step, atom economical synthesis of thieno[2,3-<i>d</i>]pyrimidin-4-amine derivatives via a four-component reactionTaoda Shi, Christopher J Zerio, Jared Sivinski, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2019
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive moleculesMckayla Stevens, Sanofar Abdeen, Nilshad Salim, et al.
Biochemistry|January 20, 2024
Human Hsp70 Substrate-Binding Domains Recognize Distinct Client ProteinsAndrew J Ambrose, Christopher J Zerio, Jared Sivinski, et al.
Oncogene|January 31, 2019
Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancerErik S Knudsen, Vishnu Kumarasamy, Amanda Ruiz, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2019
A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78Andrew J Ambrose, Christopher J Zerio, Jared Sivinski, et al.
Bioorganic & Medicinal Chemistry|November 10, 2022
Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosolSiddhi Chitre, Anne-Marie Ray, Mckayla Stevens, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Seminars in Cancer Biology|June 8, 2021
Targeting NRF2 to treat cancerJared Sivinski, Donna D Zhang, Eli Chapman
Analytical Chemistry|October 27, 2021
UniDecCD: Deconvolution of Charge Detection-Mass Spectrometry DataMarius M Kostelic, Ciara K Zak, Yang Liu, et al.
Bioorganic & Medicinal Chemistry|October 2, 2020
Analogs of nitrofuran antibiotics are potent GroEL/ES inhibitor pro-drugsMckayla Stevens, Chris Howe, Anne-Marie Ray, et al.
Bioorganic & Medicinal Chemistry|May 10, 2021
Exploiting the HSP60/10 chaperonin system as a chemotherapeutic target for colorectal cancerAnne-Marie Ray, Nilshad Salim, Mckayla Stevens, et al.
European Journal of Organic Chemistry|December 21, 2019
A one-step, atom economical synthesis of thieno[2,3-<i>d</i>]pyrimidin-4-amine derivatives via a four-component reactionTaoda Shi, Christopher J Zerio, Jared Sivinski, et al.
Bioorganic & Medicinal Chemistry Letters|March 11, 2019
HSP60/10 chaperonin systems are inhibited by a variety of approved drugs, natural products, and known bioactive moleculesMckayla Stevens, Sanofar Abdeen, Nilshad Salim, et al.
Biochemistry|January 20, 2024
Human Hsp70 Substrate-Binding Domains Recognize Distinct Client ProteinsAndrew J Ambrose, Christopher J Zerio, Jared Sivinski, et al.
Oncogene|January 31, 2019
Cell cycle plasticity driven by MTOR signaling: integral resistance to CDK4/6 inhibition in patient-derived models of pancreatic cancerErik S Knudsen, Vishnu Kumarasamy, Amanda Ruiz, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2019
A high throughput substrate binding assay reveals hexachlorophene as an inhibitor of the ER-resident HSP70 chaperone GRP78Andrew J Ambrose, Christopher J Zerio, Jared Sivinski, et al.
Bioorganic & Medicinal Chemistry|November 10, 2022
Bis-aryl-α,β-unsaturated ketone (ABK) chaperonin inhibitors exhibit selective cytotoxicity to colorectal cancer cells that correlates with levels of aberrant HSP60 in the cytosolSiddhi Chitre, Anne-Marie Ray, Mckayla Stevens, et al.
Pageof 2